Diets & Weight Loss

Neoplasm

A tumor

Question: In using the neoplasm table, what do you do when there is no code in cancer in situ? When using the neoplasm table in the ICD-9-CM, how would one code cancer in situ of the temporal lobe?

Answer: You'll never find it there. What you're probably looking for is under skin: Ca in situ of temple or similar.

 


Neoplasm Related Products and News

Managing Cancer Calls for Aggressive Approach

AllAfrica.com
For the malignant or neoplasm to grow, means the immune cells or body defense has been defeated to a certain extent. It is therefore a hazardous mistake to mix hospitalised cancer patients with others. Some cancer patients develop infections that can ...
 

A 54-year-old woman with bilateral hydronephrosis

Healio
She underwent CT-guided biopsy of her pelvic lymphadenopathy. Fine-needle aspiration biopsy of the retroperitoneal mass revealed a malignant neoplasm with hyperchromatic pleomorphic cells with nuclear molding and necrosis. The cells were negative for ...
 

Stemline Therapeutics Inc.: Stemline Therapeutics Provides Second Quarter ...

The Wall Street Transcript
Opened multicenter trial with SL-401 in advanced blastic plasmacytoid dendritic cell neoplasm (BPDCN) and acute myeloid leukemia (AML). Stemline has opened a multicenter, open-label study in BPDCN and AML. The trial will include a brief lead-in that ...
 

FDA Grants Priority Review to Ruxolitinib in Polycythemia Vera

OncLive
The rates of grade 3/4 anemia and thrombocytopenia were less in the ruxolitinib arm compared with best available therapy (1.8% vs 5.5% and 0% vs 3.6%, respectively). Symptom improvement by Myeloproliferative Neoplasm Symptom Assessment Form ...
 

Prediction Tool for Readmissions Due to End-of-Life Care

The Hospitalist Online
The four factors that were significantly associated with 30-day PAR for end-of-life care issues were: neoplasm (OR 5.6, 95% CI: 2.85-11.0), opiate medication at discharge (OR 2.29, 95% CI: 1.29-4.07), Elixhauser comorbidity index, per five-unit ...
 

Stemline Therapeutics to Present at the Wedbush Life Sciences Management ...

MarketWatch
SL-401 has demonstrated single-agent activity, including durable complete responses (CRs), in a Phase 1/2 trial in several indications including blastic plasmacytoid dendritic cell neoplasm (BPDCN) and relapsed or refractory acute myeloid leukemia (AML).
 

FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 ...

CNNMoney
Mutations in these kinases have been shown to be directly related to the development of a variety of blood-related cancers, including myeloproliferative neoplasms, leukemia and lymphoma. Pacritinib may offer an advantage over other JAK inhibitors ...
 

Bidness Etc

FDA grants fast track designation to pacritinib for myelofibrosis
Healio
 

Antimicrobial susceptibility testing effectively eradicated H. pylori

Healio
Researchers from Korea completed a clinical study of 112 H. pylori-positive patients with gastric epithelial neoplasm from November 2011 to October 2012. One-half of the cohort was randomly assigned to antibiotics determined by antimicrobial ...
 

TOMMYSLAV: BEAUTIFUL STRANGER ? Episode 10 by @tomi_adesina

360Nobs.com
You have seen the neoplasm, it is better to let her do radiotherapy. Besides, I think we are going to have problems gaining access to the tumour because of the size and location. It is at the skull base, man. Think. There are many possible outcomes of ...